Eslami, M., Ermolaev, N., Kronberger, C., Schmid, L., Poledniczek, M., Gregshammer, B., Kösters, A., Alasti, F., Kammerlander, A. A., Rettl, R., Duca, F., Binder, C., Kästner, J., Marculescu, R., Haslacher, H., Eslam, R. B. (2026). Fibroblast growth factor 23 is associated with cardiac disease severity in transthyretin amyloid cardiomyopathy. Scientific Reports. https://doi.org/10.1038/s41598-026-51879-z